Dorastine
- Level
- Commodity
- Parent
- 51313500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313505This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3087NKH40A. European Medicines Agency schedules Dorastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06370MIG. Dorastine generally arises in the molecular formula C20H22CLN3. The term DORASTINE is an International Non-Proprietary Name or INN. DORASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dorastine under HS 29333999 and SITC 51574. As of Q4 2014, DORASTINE remains the US FDA Preferred Term for this commodity. Dorastine bears US NLM identifiers UMLS ID C2699801 and NCI Concept Code C76061. SMILES: CLC1CC2C3C(N(C2CC1)CCC1CCC(NC1)C)CCN(C3)C.
Same parent
Under 51313500 · 13Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.